The "rapid decliner" COPD phenotype

I. Cerveri, A. G. Corsico, R. Niniano, V. Ronzoni, R. Cavalli, A. Grosso, A. Foresi, F. Imberti, T. Galasso, E. Tsana Tegomo, E. Pozzi (Pavia, Italy)

Source: Annual Congress 2010 - COPD: diagnosis
Session: COPD: diagnosis
Session type: Thematic Poster Session
Number: 4037
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Cerveri, A. G. Corsico, R. Niniano, V. Ronzoni, R. Cavalli, A. Grosso, A. Foresi, F. Imberti, T. Galasso, E. Tsana Tegomo, E. Pozzi (Pavia, Italy). The "rapid decliner" COPD phenotype. Eur Respir J 2010; 36: Suppl. 54, 4037

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The "rapid decliner" as a COPD phenotype associated with predominant emphysema
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

The "susceptibility to exacerbation" phenotype in COPD and response to pulmonary rehabilitation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011

Imbalances in TNFα in patients with a TNFα polymorphism and a COPD phenotype
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

Helicobacter pylori infection in COPD
Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Year: 2010

COPD phenotypes
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015




COPD phenotypes
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016



Hedgehog-interacting protein (HHIP) polymorphisms and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases
Year: 2011

Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012


Does SpO2 correlate with SaO2 in stable COPD patients?
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012


GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Are there any differences between Tunisian and European COPD phenotypes?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



CAT in COPD phenotypes (POPE study)
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Predictors of PAO2 and PaCO2 in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009

Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

A proposal of COPD phenotypes
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

Effect of ivacaftor on lung clearance index and FEV1 in subjects with CF who have the G551D-CFTR mutation and mild lung disease
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012